MAUDE Adverse Event Report: STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS

Model Number	VICMO12.6
Medical Device Problem Code	Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes	Blurred Vision (2137); Toxic Anterior Segment Syndrome (TASS) (4469)
Date of Event	08/02/2024
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
A4: unk a5: unk a6: unk d6b: na h6: health effect - impact code (f): additional medications: 4644 - steroid, levofloxacin hydrate, betamethasone butyrate propionate, bromfenac sodium hydrate and hyaluronic acid h6 - work order search: no similar complaint was reported for units within the same lot.H6: device history record (dhr) review: the dhr review indicated that the product has been manufactured within the established process parameters and that there is no indication that the manufacturing and/or processing of the device contributed to the complaint issue.H11: manufacturer narrative: a review of the device labeling was completed.Intraocular inflammation is identified in the labeling as known potential adverse event following icl implantation.The dfu provides the surgeon instruction for complete ovd removal.Precaution: (6) after inserting this product, aspirate the viscoelastic substance completely from inside the eye.Do not use highly viscous viscoelastic substances that are difficult to aspirate completely.Toxic anterior segment syndrome (tass) is an acute sterile postoperative inflammation that can occur after uncomplicated or complicated intraocular surgery.While improper sterilization and contamination of surgical instruments remains the most common risk factor associated with tass, ocular viscoelastic, and improper preparation of antibiotics for intracameral injection may also lead to tass.An exact cause could not be determined as the event could be multifactorial in nature including patient and/or procedure related factors.Claim # (b)(4).
Event or Problem Description
A facility representative reported that following the implant of an implantable collamer lens into the patient's eye, mild toxic anterior segment syndrome (tass) was diagnosed thirty days after initial implantation.Patient complained of blurred vision and photophobia.Concomitant products used intraoperatively included opegan viscoelastic and the sfc-45 cartridge with foam tip plunger.Diagnostic culture was not performed.One week after surgery the patient was prescribed standard steroid and treatment included: levofloxacin hydrate, betamethasone butyrate propionate, bromfenac sodium hydrate and hyaluronic acid.After the onset of postoperative inflammation, the patient was started with betamethasone eye drops two times and after one month, was reduced to one time.The lens remains implanted with the issue resolved.Per post-op visit, patient condition was bcva: 20/13; iop: 17 mmhg.The reporter does not provide a cause for the event.
Additional Manufacturer Narrative
Additional information: b5 - it was later reported that 70 postoperative days inflammatory recovery was observed.It was additionally provided "at 1 month postoperatively, there was significant kp on the back surface of the icl, which did not affect vision because there was no kp in the center of the icl, and patient symptoms were not evident.Mydriatic examination revealed kp only on the optical and back surface of the icl.Steroid eye drops were resumed, and kp decreased within a month, and the patient is still under observation." a further update noted no abnormality and confirmed to be in good condition in february 25, 2025.(b)(4).

• Brand Name: IMPLANTABLE COLLAMER LENS (ICL)
• Common Device Name: PHAKIC INTRAOCULAR LENS
• Manufacturer (Section D): STAAR SURGICAL COMPANY; 1911 walker avenue; monrovia CA 91016
• Manufacturer (Section G): STAAR SURGICAL COMPANY; 1911 walker avenue; monrovia CA 91016
• Manufacturer Contact: joselene muniz ; 1911 walker avenue; monrovia, CA 91016 ; 6263037902
• MDR Report Key: 20846318
• Report Number: 2023826-2024-05337
• Device Sequence Number: 18167847
• Product Code: MTA
• UDI-Device Identifier: 00840311302093
• UDI-Public: (01)00840311302093(11)231006(17)260930
• Combination Product (Y/N): N
• Initial Reporter Country: JA
• PMA/510(K) Number: P030016
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2024
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: Other,Foreign,Health Professional,Distributor
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup
• Report Date (Section B): 11/08/2024

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Expiration Date: 09/30/2026
• Device Model Number: VICMO12.6
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 11/08/2024
• Supplement Date Received by Manufacturer: 08/20/2025
• Initial Report FDA Received Date: 12/04/2024
• Supplement Report FDA Received Date: 08/21/2025
• Was Device Evaluated by Manufacturer? (Y/N): No
• Date Device Manufactured: 10/06/2023
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: CARTRIDGE MODEL SFC-45 - LOT # UNK; FOAM TIP PLUNGER MODEL FTP - LOT # UNK; INJECTOR MODEL AND LOT # UNK
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 29 YR
• Patient Sex: Female